 | Up a level |
Journal Article
Flamme, H., Krallmann, S., Poll-Wolbeck, S. J., Krueger, M., Berkessel, A., Hallek, M. and Kreuzer, K. -A (2014). Novel NO-ASA derivatives are new promising agents in the therapy of chronic lymphocytic leukemia (CLL), other hematologic neoplasia and solid tumors. Oncol. Res. Treat., 37. S. 221 - 222. BASEL: KARGER. ISSN 2296-5262
Krallmann, S., Liakos, A., Flamme, H., Poll-Wolbeck, S. J., Krueger, M., Berkessel, A., Hallek, M. and Kreuzer, K-A (2014). Modifications of Nitric Oxide Donating Aspirin (NO-ASA): Enhanced sensitivity and selectivity towards TP53 mutated chronic lymphocytic leukemia (CLL) cells. Oncol. Res. Treat., 37. S. 52 - 53. BASEL: KARGER. ISSN 2296-5262